MedTrace Logo

"Gluten Friendly" Treatment in Celiac Disease

NCT03137862 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2018-08-09

No results posted yet for this study

Summary

A PROSPECTIVE, double blind, placebo-controlled trial

Conditions

Interventions

OTHER

Gluten free bread

patients will receive bread containing 3 g of cornstarch daily for 12 weeks; these patients will serve as controls

DIETARY_SUPPLEMENT

Gluten friendly bread 3g/day

patients will have to continue the GFD supplemented with 3 gr of "gluten friendly" bread daily for 12 weeks

DIETARY_SUPPLEMENT

Gluten friendly bread 6g/day

patients will have to continue the GFD supplemented with 6 gr of "gluten friendly" bread daily for 12 weeks

Sponsors & Collaborators

  • University of Foggia

    collaborator OTHER

  • Casa Sollievo della Sofferenza IRCCS

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2017-04-02
Completion
2018-01-15

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03137862 on ClinicalTrials.gov